Potential relationship and clinical significance of miRNAs and Th17 cytokines in patients with multiple myeloma

Leuk Res. 2014 Sep;38(9):1130-5. doi: 10.1016/j.leukres.2014.07.005. Epub 2014 Jul 22.

Abstract

We evaluated the potential relationship between miRNAs and Th17 cytokines in multiple myeloma (MM) patients. Twenty-seven newly diagnosed myeloma patients and eight normal donors were studied. We determined that the relative expression levels of miR-15a/16, miR-34a, miR-194 in MM patients were significantly lower than those in the healthy controls with exception for miR-181a/b, which showed significantly higher in MM patients (P<0.05). In contrast, the levels of IL-17, IL-21 and IL-27 were up-regulated in MM patients compared to healthy controls while IL-22 was down-regulated (P<0.05). The expression patterns of them were differentially present in various groups according to the International Staging System (ISS) criteria. Up-regulated IL-17, IL-21 and IL-27 may potentially down-regulate the expression of several miRNAs in MM patients. Establishment of the relationship may be useful for understanding the pathogenesis of MM and for clinical diagnosis of the disease.

Keywords: Multiple myeloma; Th17 cytokines; miRNAs.

MeSH terms

  • Aged
  • Case-Control Studies
  • Cytokines / blood
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Interleukin-17 / blood*
  • Interleukins / blood*
  • Male
  • MicroRNAs / genetics*
  • Middle Aged
  • Multiple Myeloma / blood*
  • Multiple Myeloma / diagnosis
  • Multiple Myeloma / genetics*
  • Multiple Myeloma / therapy
  • Prognosis
  • Th17 Cells / metabolism
  • Treatment Outcome

Substances

  • Cytokines
  • Interleukin-17
  • Interleukins
  • MYDGF protein, human
  • MicroRNAs
  • interleukin-21